Cronos Group Inc. (CRON): Share Repurchases

Annual figures by period end, from SEC filings.

$9.74M
Year ended 2025-12-31
$38.99M
Trailing 12 months to 2026-06-30
2023-12-31: $02024-12-31: $02025-12-31: $9.74M$9.74M
2023-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$9.74Mn/a2026-02-26, From 2025-01-01
2024-12-31$0n/a2026-02-26, From 2024-01-01
2023-12-31$0n/a2026-02-26, From 2023-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Cronos Group Inc. (CRON)2025-12-31$9.74Mn/a
Natural Alternatives International Inc (NAII)2025-06-30$178.0K-19.5%
Niagen Bioscience, Inc. (NAGE)2025-12-31$251.0Kn/a
biote Corp. (BTMD)2025-12-31$3.37M-39.9%
Mannatech Inc (MTEX)2024-12-31$0-100.0%
C21 Investments Inc. (CWLXF)2026-03-31$103.0K-62.8%
USANA Health Sciences Inc (USNA)2026-01-03$27.51M+191.3%

Compare CRON, NAII, NAGE, BTMD side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗